We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Agilent Names Nick Roelofs VP of Life Sciences Solutions Unit

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Agilent Technologies Inc. has announced the appointment of Nick Roelofs, Ph.D., as vice president and general manager, Life Sciences Solutions Unit.

This Agilent business unit serves basic research, disease research and pharmaceutical markets, which include genomics, proteomics, metabolomics, drug discovery/development and pharmaceutical quality control/quality assurance.

"Nick understands the needs of scientists and scientific organizations, and what it takes from a business standpoint to successfully serve these markets," said Chris van Ingen, president, Agilent Life Sciences and Chemical Analysis. "We’re glad he decided to join Agilent."

Roelofs brings 19 years of life science and diagnostics experience to Agilent. Previously, he was group operations officer of Bio-Rad Laboratories’ Life Science Group.

He has also served as chief operating officer of Stratagene and has held senior positions at ABI and Baxter Diagnostic.

His doctorate in organic chemistry is from the University of Nevada, Reno, and he holds a Master of Science in organic chemistry from Iowa State University

At Agilent, Roelofs is responsible for product profit and loss of the business group that includes microarrays, liquid chromatographs, microfluidics, mass spectrometers used in life science, capillary electrophoresis and informatics.